Article Information
Published By
Online ISSN
History
- Published online October 13, 2022.
Article Versions
- You are currently viewing a previous version of this article (October 13, 2022 - 06:04).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Manuela Funke-Chambour1,2⇑,
- Namrata Kewalramani1,
- Carlos Machahua1,2,
- Venerino Poletti3,
- Athol U. Wells4,5 and
- Jacques Cadranel6
- 1Department for BioMedical Research DBMR, Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
- 2Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
- 3Department of Thoracic Diseases, “GB. Morgagni” Hospita, Forlì, Dipartimento di Medicina Specialistica Diagnostica e Sperimentale (DIMES) University of Bologna, Italy
- 4Royal Brompton and Harefield NHS Foundation Trust, London, UK
- 5National Heart and Lung Institute, Imperial College London, London, UK
- 6Department of Pulmonary Medicine and Thoracic Oncology; Constitutive Reference Center of Rare Pulmonary Diseases, AP-HP, Hôpital Tenon and GRC04 Theranoscan, Sorbonne Université, Paris, France
- Corresponding author: Manuela Funke-Chambour (manuela.funke-chambour{at}insel.ch)
Article usage
Altmetrics
Vol 9 Issue 1
Table of Contents
Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
